The story of Henrietta Lacks and the uniqueness of HeLa cells
2023年8月28日 · Doctors took cells from Henrietta Lacks without her consent 71 years ago. Known as HeLa cells, they have since revolutionized research — but at what cost, and who has really benefitted?
The Legacy of Henrietta Lacks | Johns Hopkins Medicine
For years, Dr. Gey, a prominent cancer and virus researcher, had been collecting cells from all patients - regardless of their race or socioeconomic status - who came to The Johns Hopkins Hospital with cervical cancer, but each sample quickly died in Dr. Gey’s lab.
Who was Henrietta Lacks? Here’s how HeLa cells became …
2023年8月1日 · In an amazing twist of fate, the aggressive cervical cancer tumor that killed Henrietta Lacks, a 31-year old African American mother, became an essential tool that helped the biomedical field...
Henrietta Lacks - Wikipedia
Henrietta Lacks (born Loretta Pleasant; August 1, 1920 – October 4, 1951) [2] was an African-American woman [5] whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line [B] and one of the most important cell lines in medical research.
The Immortal Life of Henrietta Lacks | Johns Hopkins Medicine
The donation of Henrietta Lacks' cells began what was the first, and, for many years, the only human cell line able to reproduce indefinitely. Her cells, known as HeLa cells for Henrietta Lacks, remain a remarkably durable and prolific line of cells used in research around the world. This guide addresses several important health care, research ...
The Importance of HeLa Cells | Johns Hopkins Medicine
Among the important scientific discoveries of the last century was the first immortal human cell line known as “HeLa” — a remarkably durable and prolific line of cells obtained during the treatment of Henrietta’s cancer by Johns Hopkins researcher Dr. George Gey in 1951.
The Story of HeLa and Henrietta Lacks - Genetics Unzipped
2020年10月8日 · We explore the story of how Henrietta Lacks’s immortal cells (known today as HeLa cells) became the go-to human cell line for biomedical research, and the impact they’ve had as a result.
'Henrietta Lacks': A Donor's Immortal Legacy : NPR
2010年2月2日 · In 1951, Henrietta Lacks died after a long battle with cervical cancer. Doctors cultured her cells without permission from her family. The story of those cells — known as HeLa cells, in...
Henrietta Lacks (1920–1951) | Embryo Project Encyclopedia
2020年10月9日 · Henrietta Lacks, born Loretta Pleasant, had terminal cervical cancer in 1951, and was diagnosed at The Johns Hopkins University in Baltimore, Maryland, where researchers collected and stored her cancer cells. Those cells went on to become the first immortal human cell line, which the researchers named HeLa.
Henrietta Lacks: How her 'immortal' cells advanced modern science
Henrietta Lacks, a poor African American tobacco farmer from Virginia, was born in August 1920 and was diagnosed with an aggressive form of cervical cancer at the age of 31.